Prot #GR40306: A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator Controlled Study To Evaulate The Efficacy And Safety Of Faricimab In Patients With Neovascular Age-Related Macular Degeneration (TENAYA)

Project: Research project

Project Details

StatusActive
Effective start/end date3/26/19 → 9/30/23

Funding

  • INC Research, LLC (Prot #GR40306)
  • Genentech, Inc. (Prot #GR40306)